John Leonard
13Patents
4h-index
30Co-inventors
60Inventor score
Filing activity: Feb 25, 2000 → Apr 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6338848B1 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Human Necessities | 45 | Expired |
| US9139580B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US8912177B2 | Method of treating polycystic kidney diseases with ceramide derivatives | Human Necessities | 8 | Active |
| US6706264B1 | Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y | Chemistry; Metallurgy | 7 | Expired |
| US6830751B1 | Use of IL-12 antagonists in the treatment of rheumatoid arthritis | Chemistry; Metallurgy | 4 | Expired |
| US11008316B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9126993B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7138115B2 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Chemistry; Metallurgy | 3 | Expired |
| US7534430B2 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Chemistry; Metallurgy | 2 | Active |
| US8012475B2 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Chemistry; Metallurgy | 1 | Active |
| US8231874B2 | Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US12060349B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10220039B2 | Method of treating polycystic kidney diseases with ceramide derivatives | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.